Skip to content

Author

Lino L. Teichmann

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Firstline treatment with ruxolitinib versus best available therapy in patients with polycythemia vera: results from the randomized RuxoBEAT trial

It is suggested that RUX may induce clinically meaningful additional disease improvements in first-line therapy of PV patients with polycythemia vera in the randomized multicenter RuxoBEAT clinical trial.

Steffen Koschmieder, S. Isfort, Lino L. Teichmann et al. · 0 citations
Open access Sep 2026

Myeloperoxidase and anti-MPO IgG synergistically enhance TLR9-mediated immune activation in ANCA-associated vasculitis.

It is demonstrated that MPO binds to extracellular DNA and protects it from nuclease degradation, and how MPO and αMPO cooperate to facilitate TLR9-dependent sensing of extracellular DNA and thus immune activation in ANCA-associated vasculitis is revealed.

Calvin Krollmann, Maria L. Saenz, Ruth-Miriam Koerber et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.